The effect of 2-amino-3-arsonopropionate and 2-amino-4-arsonobutyrate on the development and maintenance of amygdala kindled seizures.

  title={The effect of 2-amino-3-arsonopropionate and 2-amino-4-arsonobutyrate on the development and maintenance of amygdala kindled seizures.},
  author={Abdul-Salam Abdul-Ghani and Philip J. E. Attwell and Henry F. Bradford},
  journal={The International journal of neuroscience},
  volume={96 3-4},
The effects of 2-a-3-arsonopropionate and 2-a-4-arsonobutyrate, the arsono analogues of aspartate and glutamate respectively, on the development of electrically-induced kindling in the amygdala, and on seizures induced in fully kindled rats, were compared to the effects of 3-amino-propylarsonate the arsono analogue of GABA. Intra-amygdaloid micro-injection of 2-a-3-arsonopropionate and 2-a-4-arsonobutyrate (10 nmol in 0.5 microl buffer phosphate) reduced the rate of epileptogenesis without… 
1 Citations
Bypassing the Blood–Brain Barrier: Direct Intracranial Drug Delivery in Epilepsies
Although an invasive procedure, bypassing the BBB by targeted intracranial drug delivery is an attractive approach to circumvent BBB-associated drug resistance mechanisms and to lower the risk of systemic and neurologic adverse effects.


The anti-epileptic effect of 3-aminopropylarsonate on electrically-kindled and N-methyl-d-aspartate-kindled amygdala
The potent antiepileptogenic and anti-convulsant activity of the arsonoanalogue of GABA appears to be non-toxic and therefore potentially useful as the basis for developing a new family of clinically useful anticonvulsants for treating epilepsy.
The protective effect of 2-chloroadenosine against the development of amygdala kindling and on amygdala-kindled seizures.
2-chloroadenosine not only acts as an anticonvulsant against electrically induced kindled seizures as described here, and against audiogenic seizures, electroshock and a variety of chemical convulsants as described by others, it prevents the development of the epileptic state by kindling-stimulation, i.e., it is antiepileptogenic.
Anti-epileptogenic and anticonvulsant activity of l-2-amino-4-phosphonobutyrate, a presynaptic glutamate receptor agonist
The results suggest the mechanisms by which presynaptically active glutamate receptor agonists block the development of the chronically epileptic state induced by electrical kindling, and indicate that their anticonvulsive activity is due to inhibition of presynaptic glutamate and/or aspartate release following blockade of Presynaptic Ca2+ entry.
Anticonvulsant and glutamate release-inhibiting properties of the highly potent metabotropic glutamate receptor agonist (2S,2′R,3′R)-2-(2′,3′-dicarboxycyclopropyl)glycine (DCG-IV)
The findings demonstrate the high potency of DCG-IV as an anticonvulsant agent and confirm a key role for group II metabotropic glutamate receptors in the control of seizure activity via their modulatory action on neuronal glutamate release.
Anticonvulsant activity of the NMDA antagonists, d(−)4-(3-phosphonopropyl)piperazine-2-carboxylic acid (D-CPP) and d(−)(E)-4-(3-phosphonoprop-2-enyl) piperazine-2-carboxylic acid (D-CPPene) in a rodent and a primate model of reflex epilepsy
The prolonged anticonvulsant action of D- CPP and D-CPPene following oral administration suggests that these compounds merit evaluation as antiepileptic therapy in man.
Blockade of both epileptogenesis and glutamate release by (1S,3S)-ACPD, a presynaptic glutamate receptor agonist
A new approach to the development of clinically effective anticonvulsants through the developed of presynaptic glutamate receptor agonists which could be administered systemically to control the extent of synaptic release of glutamate is suggested.
Specific group II metabotropic glutamate receptor activation inhibits the development of kindled epilepsy in rats
It is suggested that the selective activation of the group II metabotropic glutamate receptors by agonists such as 2R,4R-APDC may be of therapeutic potential in the treatment of seizure disorders.
Potent oral anticonvulsant action of CPP and CPPene in DBA/2 mice.
CPP and its unsaturated analogue, CPPene, have potent anticonvulsant activity against sound-induced clonic seizures in DBA/2 mice.
Subtypes of metabotropic excitatory amino acid receptor distinguished by stereoisomers of the rigid glutamate analogue, 1-aminocyclopentane-1,3-dicar☐ylate
The results indicate the usefulness of 1S,3S-ACPD as a tool to selectively activate one of these subtypes and suggest the presence in guinea-pig cerebral cortex of two distinct subtypes of ACPD receptor coupled to phosphoinositide hydrolysis and the inhibition of forskolin-stimulated cAMP accumulation.
The influence of strychnine-insensitive glycine receptor agonists and antagonists on generalized seizure thresholds
The concept that potent and selective gly2 receptor antagonists may provide a useful, novel class of anticonvulsant agents in fully amygdala kindled rats is supported.